Tomasz Lipniacki

Institute of Fundamental Technological Research

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Ewelina Bięga

POLAND

View details

Zbigniew Korwek

Instytut Podstawowych Problemów Techniki PAN

POLAND

View details

Maciej Czerkies

Assistant professor

Institute of Fundamental Technological Research

POLAND

View details

Paolo Armando Gagliardi

Associate Professor

University of Turin

ITALY

View details

Marek Kochańczyk

Assistant Professor

Institute of Fundamental Technological Research, Polish Academy of Sciences

POLAND

View details

Ali Abdi

New Jersey Institute of Technology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomasz Lipniacki

Research Interests

Explore related searches

Contact this professor

Articles (13)

Information transmission in a cell monolayer: A numerical study

Antagonism between viral infection and innate immunity at the single-cell level

A plausible identifiable model of the canonical NF-κB signaling pathway

The MAPK/ERK channel capacity exceeds 6 bit/hour

Nonself RNA rewires IFN-β signaling: A mathematical model of the innate immune response

Single-Cell Measurements and Modeling and Computation of Decision-Making Errors in a Molecular Signaling System with Two Output Molecules

Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons

Slow nucleosome dynamics set the transcriptional speed limit and induce RNA polymerase II traffic jams and bursts

The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations

Pareto-based evaluation of national responses to COVID-19 pandemic shows that saving lives and protecting economy are non-trade-off objectives

Electrochemical Immunosensors Based on Screen-Printed Gold and Glassy Carbon Electrodes: Comparison of Performance for Respiratory Syncytial Virus Detection

Super-spreading events initiated the exponential growth phase of COVID-19 with ℛ 0 higher than initially estimated

Collaborators (6)

Ewelina Bięga

Zbigniew Korwek

Maciej Czerkies

Paolo Armando Gagliardi

Marek Kochańczyk

Ali Abdi

Make your next move.